Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT02772575
What this trial is testing

See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

Who this might be right for
Liver CancerLiver Metastases
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00095992
What this trial is testing

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
NCIC Clinical Trials Group 15
Post-approval studies (Phase 4)Study completedNCT04288323
What this trial is testing

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

Who this might be right for
Liver CancerLiver CirrhosesLiver Carcinoma
University of California, San Diego 79
Testing effectiveness (Phase 2)Ended earlyNCT02575339
What this trial is testing

MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerHCC
Kathy Miller 11
Testing effectiveness (Phase 2)Ended earlyNCT04442581
What this trial is testing

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
University of Washington 2
Post-approval studies (Phase 4)UnknownNCT00555334
What this trial is testing

Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 200
Early research (Phase 1)Study completedNCT00012181
What this trial is testing

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

Who this might be right for
Recurrent Childhood Brain Stem GliomaRecurrent Childhood Cerebellar AstrocytomaRecurrent Childhood Cerebral Astrocytoma+19 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912
What this trial is testing

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Who this might be right for
Metastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT00039078
What this trial is testing

Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Allan Tsung
Not applicableActive Not RecruitingNCT05128123
What this trial is testing

Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 1,600
Testing effectiveness (Phase 2)Looking for participantsNCT07447050
What this trial is testing

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric (Stomach) Cancer+7 more
University of California, Irvine 24
Not applicableStudy completedNCT05989789
What this trial is testing

Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic Patients

Who this might be right for
Liver CancerLiver Cirrhosis
Clarunis - Universitäres Bauchzentrum Basel 2
Testing effectiveness (Phase 2)WithdrawnNCT01669668
What this trial is testing

Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Carcinoma, Hepatocellular
Washington University School of Medicine
Post-approval studies (Phase 4)Study completedNCT01203787
What this trial is testing

Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Florida 120
Not applicableUnknownNCT03609268
What this trial is testing

Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma

Who this might be right for
Recurrent Hepatocellular CarcinomaMicrowave AblationStereotactic Body Radiotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 110
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Not applicableLooking for participantsNCT04745390
What this trial is testing

Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver Metastases
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT06679985
What this trial is testing

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Coherus Oncology, Inc. 72
Not applicableEnded earlyNCT02908048
What this trial is testing

Extracellular RNA Markers of Liver Disease and Cancer

Who this might be right for
Hepatocellular CarcinomaBiliary Tract CancerCirrhosis+1 more
Mayo Clinic 1,865
Testing effectiveness (Phase 2)Ended earlyNCT01032850
What this trial is testing

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
New Mexico Cancer Research Alliance 15
Next Page